SCP-2375
Euclid
~
medium confidence
SCP-2375
Expected annual
$35.4M
One-time setup
$36.8M
Annual recurring
$34.3M
Personnel
183
Initial capital/setup costs are roughly $36.8M driven by vehicles, equipment, lab/R&D and a contingency reserve; ongoing annual operating costs are approximately $34.3M/yr driven primarily by MTF staffing, research/monitoring, legal/cover operations and logistics.
One-Time Capital Costs
Total: $36.8M
Annual Recurring Costs
Total: $34.3M/yr
Cost Scenarios
📊
Baseline
(baseline)
$34.3M/yr
Normal year with routine operations, no major incidents beyond expected raids and research activity.
routine_deployments
ongoing_research
regular_maintenance
🚨
Minor Incident
$35.3M/yr
One or more localized outbreak responses requiring additional raids, overtime, forensic testing and short-term community remediation.
localized_outbreak
increased_raids
spike_in_testing
🚨
Large Scale Quarantine
$84.3M/yr
City-level (or larger) containment/quarantine response with mass logistics, enforcement, and emergency disposal/medical surge.
urban_mass_spread
failed_local_containment
public_exposure
Personnel
183 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 120 | [#1] Primary operational force (120 FTEs) referenced explicitly in notes. |
| Research Scientist | 20 | [#10] Biomedical research staff funded within the research program budget. |
| Lab Technician | 10 | [#8] Forensic/pathology technicians supporting labs and sample processing. |
| Medical Officer | 5 | [#20] Field medics and long-term healthcare staff for responders. |
| Engineer / Maintenance | 8 | [#6, #7] Vehicle, generator and facility maintenance staff. |
| Administrative Staff | 15 | [#2] HQ management, finance, HR, procurement and scheduling. |
| IT Staff | 3 | [#21, #27] IT/sysadmin and incident-management support. |
| Legal Counsel | 2 | [#16] In-house counsel coordinating with external legal resources; additional legal costs are contract/retainer-based. |
Confidence Notes
Analyst notes provide detailed line items and reasonable ranges, enabling an order-of-magnitude estimate; uncertainty remains in frequency/severity of outbreaks and long-term R&D timelines, so confidence is medium.